Trial Profile
A Single-Center, Single-Dose, Double-Blind, Modified-Double-Dummy, Placebo and Active-Controlled, Randomized, Three-Way, Six-Sequence Cross-Over Study to Investigate the Effect of JNJ-39758979 on Histamine Induced Pruritus in Healthy Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 27 Nov 2014
Price :
$35
*
At a glance
- Drugs JNJ 39758979 (Primary)
- Indications Asthma; Atopic dermatitis; Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Janssen Research & Development
- 27 Nov 2014 New trial record